We're the UK's leading bowel cancer charity

Virtual education event: Chemotherapy and immunotherapy updates in colorectal cancer

Event details

  • Date: Tuesday 4 November
  • Time: 2-3.15pm
  • Who's it for: Colorectal clinical nurse specialists, endoscopists and specialist screening practitioners
  • Where: online via Zoom

Sign up now

The session, led by Professor Mark Saunders, Consultant Clinical Oncologist at The Christie NHS Foundation Trust, will provide a brief history of the evolution of chemotherapy over the last 25 years and concentrate on the management of patients with chemotherapy including genetic mutation targeted therapies and immunotherapy.

You’ll also have the opportunity to participate in a Q&A session at the end of the event.

Learning outcomes:

  • Gold standard lines of chemotherapy for patients with metastatic colorectal cancer
  • What mutations should be targeted and their outcomes
  • Immunotherapy for dMMR/MSI-H metastatic colorectal cancer

Sign up now

A healthcare professional is sitting opposite the camera in a white coat holding a black clipboard. To the left of the image a patient is sat in a grey top listening to the healthcare pofessional. Documents and a tablet can be seen on the white table they are sat at, in the background a large indoor plant is visible.

Speaker bio

Professor Mark Saunders, MBBS, MRCP, FRCR, PhD, received his medical degree from Charing Cross Hospital, London, UK, in 1986. He spent 5 years working in general medicine before specialising in oncology, first at the Churchill Hospital in Oxford and later at The Christie in Manchester where was made a consultant at in 1999.

His main area of interest is running all phases of chemotherapy and radiotherapy clinical trials evaluating novel agents with associated response / toxicity biomarkers and radiology (colorectal cancer, anal cancer, and pseudomyxoma). He has written a series of protocols for clinical trials that have been funded, completed and published. He also chairs or is a member of a number of Trial Management Groups (TMGs) and Data Monitoring Committees (DMCs). Professor Saunders has been a member of number of NCRN and CRUK committees and previously chaired the Northern Cancer Drug Fund (CDF) committee. He works closely with Bowel Cancer UK, a charity dedicated to raising awareness of bowel cancer, improving the quality of life of those affected and, ultimately, reducing deaths from bowel cancer.

A headshot of Professor Mark Saunders smiling into camera against a plain wall wearing a dark suit jacket and white shirt with a pattern of electric guitars on it.

Sign up now

Please enter your details below to register

We take your privacy seriously and promise to never sell your data. You can find out more about your rights, how we use your personal information and how we keep your details safe and secure by reading our Privacy Policy. For more information, to update your choices or to stop us sending you updates, email [email protected] or call 020 7940 1760.

If you input information about your health in the form above you agree to Bowel Cancer UK storing and using this information to help us send you more relevant information as well as understand you better. You can request that we delete this information, whenever you'd like, by contacting us on [email protected].

Thanks supporter

Thanks for signing up for this great campaign. To complete the setup of your JustGiving page you need to first create an account for [email protected], please enter a new password to use below. Alternatively if you already have an account and would like to use it just click here.

Thanks supporter

Thanks for signing up for this great campaign. To complete the setup of your JustGiving page you need to login to your [email protected] account, please enter the password for that account below. Alternatively if you have a different account you would like to use just click here.

Forgotten password

Hi supporter, do you want to send a password reminder?.

JustGiving Login

Hi supporter, please enter your JustGiving login details below and we'll handle the rest.